GENNEXT Trademark
GENNEXT is a USPTO trademark filed by GenNext Technologies, Inc.. Status: Registered.
Trademark Facts
| Mark | GENNEXT |
|---|---|
| Serial Number | 97164613 |
| Registration Number | 6967357 |
| Status | Registered |
| Filing Date | 2021-12-09 |
| Registration Date | 2023-01-31 |
| Mark Type | Word |
| Nice Classes | 009 (Electronics & Software), 042 (Software & IT) |
| Owner | GenNext Technologies, Inc. |
| Attorney of Record | David I. Greenbaum |
| Prosecution Events | 20 |
| Latest Event | REAP on 2025-05-14 |
Goods & Services
Scientific apparatus and instruments and analysis apparatus and analysis instruments, namely, analytical apparatus for laboratory purposes for protein analysis, all for research, analysis and diagnosis purposes; laboratory analysis apparatus, namely, analytical apparatus for laboratory purposes for protein analysis using high energy plasma photolysis; imaging apparatus and instruments for use in the study of proteins in drug development, pharmaceutical research, biotechnology, biopharmaceutical and biosimilar research; Dosimeters, radical dosimeters, UV detectors, radical dosimeters for use in protein analysis; dosimeters for measuring hydroxyl radical concentration; dosimeters to provide real-time photometric absorbance measurements, enabling the assessment of effective hydroxyl radical concentration; downloadable computer software for protein analysis; downloadable computer software for analysis of protein higher order structure (HOS); downloadable computer software for processing data from hydroxyl radical protein footprinting (HRPF); downloadable computer software for use in drug discovery, pharmaceutical research, biotechnology, biopharmaceutical and biosimilar research; Scientific research; chemical research; biochemical research; technical consultancy and project planning in the field of biological research relating to proteins; research and development in the field of proteins for others; conducting scientific studies in the field of biomolecules and pharmaceuticals; conducting scientific studies in the field of proteins; conducting scientific studies in the field of high order structural protein analysis; conducting biosimilar-originator high order structural protein scientific studies; conducting expression platform high order structural protein scientific studies; conducting formulation high order structural protein scientific studies; conducting antibody-antigen epitope and paratope mapping for scientific purposes; conducting protein- ligand high order structural protein scientific studies; conducting protein-protein high order structural protein scientific studies; conducting receptor-drug high order structural protein scientific studies